Efficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review
Authors:
- Daniel HerzDHDaniel Herz
- Sandra HauptSHSandra Haupt
- Rebecca Tanja ZimmerRZRebecca Tanja Zimmer
- Nadine Bianca WachsmuthNWNadine Bianca Wachsmuth
- Janis SchierbauerJanis Schierbauer
- Paul ZimmermannPZPaul Zimmermann
- Thomas VoitTVThomas Voit
- Ulrike ThurmUTUlrike Thurm
- Kayvan KhoramipourKKKayvan Khoramipour
- Sian RilstoneSRSian Rilstone
- Othmar MoserOMOthmar Moser
Open Access
Abstract
Over the last decade, studies suggested that dietary behavior modification, including fasting, can improve metabolic and cardiovascular markers as well as body composition. Given the increasing prevalence of people with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) and the increasing obesity (also in combination with diabetes), nutritional therapies are gaining importance, besides pharmaceutical interventions. Fasting has demonstrated beneficial effects for both healthy individuals and those with metabolic diseases, leading to increased research interest in its impact on glycemia and associated short- and long-term complications. Therefore, this review aimed to investigate whether fasting can be used safely and effectively in addition to medications to support the therapy in T1DM and T2DM. A literature search on fasting and its interaction with diabetes was conducted via PubMed in September 2022. Fasting has the potential to minimize the risk of hypoglycemia in T1DM, lower glycaemic variability, and improve fat metabolism in T1DM and T2DM. It also increases insulin sensitivity, reduces endogenous glucose production in diabetes, lowers body weight, and improves body composition. To conclude, fasting is efficient for therapy management for both people with T1DM and T2DM and can be safely performed, when necessary, with the support of health care professionals.Keywords
This publication has 97 references indexed in Scilit:
- The impact of religious fasting on human healthNutrition Journal, 2010
- Recommendations for Management of Diabetes During RamadanDiabetes Care, 2010
- Leptin therapy in insulin-deficient type I diabetesProceedings of the National Academy of Sciences, 2010
- Intermittent fasting does not affect whole-body glucose, lipid, or protein metabolismThe American Journal of Clinical Nutrition, 2009
- Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistanceAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Role of Growth Hormone in Regulating Lipolysis, Proteolysis, and Hepatic Glucose Production during FastingThe Journal of Clinical Endocrinology & Metabolism, 2008
- The effect of total starvation and very low energy diet in lean men on kinetics of whole body protein and five hepatic secretory proteinsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Interleukin-6, C-Reactive Protein and Biochemical Parameters during Prolonged Intermittent FastingAnnals of Nutrition and Metabolism, 2007
- Type 1 diabetes and prolonged fastingDiabetic Medicine, 2007
- Fuel Metabolism in StarvationAnnual Review of Nutrition, 2006